LOS ANGELES & SEOUL, South Korea--(BUSINESS WIRE)--Cynvenio Biosystems, Inc., a diagnostics company dedicated to enabling the new era of individualized medicine for all cancer patients, and ATGen Global, a private biotech company in Korea that manufactures and supplies a wide array of recombinant proteins and antibodies worldwide, today announced the companies have formed a collaborative partnership to bring ATGen’s NK Vue™ test to the US market.
Help employers find you! Check out all the jobs and post your resume.
